Dr. Larry Goldenberg is awarded the Queen's 2012 Diamond Jubilee Medal

Date Posted: 
2012-03-16

Dr. Larry Goldenberg, Professor and Head, Department of Urologic Sciences at Vancouver General Hospital and UBC and Director of Development at the Vancouver Prostate Centre, will be awarded the Queen's 2012 Diamond Jubilee Medal on April 11th, 2012. The Medal honours significant contributions and achievements made by Canadians.

Dr. Goldenberg has contributed significantly to championing research by raising funds to create the infrastructure for the Prostate Centre, which has become a leading National Centre for Excellence in prostate research, education and healthcare delivery.   He has also long been a champion of technology, and was the driving force behind the acquisition of a state-of-the-art da Vinci Robot at VGH which is used in many types of minimally invasive surgery including kidney transplant.

In addition, Dr. Goldenberg is the Director of Men's Health Initiative of BC, a large-scale initiative aimed at improving men's health and quality of life through leadership, awareness and education campaigns, research, and disseminating best practices in clinical care.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

PCF BC

Ride to Live 2018 and 50-50 Draw: May 27

The West Coast Motorcycle Ride to Live, raising funds for Prostate Cancer Foundation BC, takes place on Sunday May 27, 2018 in Vancouver, Victoria & the Fraser Valley. Follow the links to join a ride or donate to a rider; or to buy a ticket for a 50/50 draw (BC residents only).

Employment

Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.